Lisheng Pharmaceutical (002393.SZ) Performance Express: Net profit of 418 million yuan in 2025, up 126.72% year-on-year

Gelonghui March 9 — Lisheng Pharmaceutical (002393.SZ) announced its 2025 performance forecast. The company achieved a total operating revenue of 1.39 billion yuan in 2025, an increase of 4.23% compared to the same period last year. The company actively expanded its market and increased product sales. Additionally, influenced by dividends from its equity affiliates, the total profit and net profit attributable to shareholders of the listed company saw significant growth; net profit attributable to shareholders of the listed company was 418 million yuan, a year-on-year increase of 126.72%.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin